From FDA reports: drug interactions between Blinded Sildenafil Citrate, Citalopram, Otilonium Bromide, Pantoprazole, Simvastatin, Warfarin
This is a study of Blinded Sildenafil Citrate, Citalopram, Otilonium Bromide, Pantoprazole, Simvastatin, Warfarin drug interactions. The study is created by eHealthMe based on reports of 7 people who take the same drugs and have drug interactionsfrom FDA.
On Dec, 31, 2014: 7 people who reported to have interactions when taking Blinded Sildenafil Citrate, Citalopram, Otilonium Bromide, Pantoprazole, Simvastatin, Warfarin are studied
Information of the patient in this study:
Conditions: Pulmonary Hypertension
- Blinded Sildenafil Citrate
- Otilonium Bromide
Drug interactions have: Pancreatitis Chronic, Pancreatic Disorder
eHealthMe real world results:
For people in general (regardless of gender or age):
Comparison with this patient's adverse outcomes:
|Interaction||Number of reports|
|Pancreatitis Chronic (chronic inflammation of pancreas)||4 (57.14%)|
|Pancreatic Disorder||4 (57.14%)|
Most common interactions experienced by people in the use of Blinded Sildenafil Citrate, Citalopram, Otilonium Bromide, Pantoprazole, Simvastatin, Warfarin:
|Interaction||Number of reports|
|Ileus Paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)||7|
|Hypertension (high blood pressure)||7|
|Deep Vein Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)||7|
|Hyperlipidaemia (presence of excess lipids in the blood)||7|
|Anaemia (lack of blood)||7|
|Dehydration (dryness resulting from the removal of water)||7|
|Hyperosmolar State (life-threatening emergency manifested by marked elevation of blood glucose)||6|
|Hypotension (abnormally low blood pressure)||6|
|Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)||6|
Most common interactions experienced by people in long term use of Blinded Sildenafil Citrate, Citalopram, Otilonium Bromide, Pantoprazole, Simvastatin, Warfarin:
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
- Subscribe the study: get notified of updates
- Post a comment: or see what other people said about the study
- Join a mobile peer support group:
- group for people who take Pantoprazole and have Pancreatitis Chronic
- group for people who take Simvastatin and have Pancreatitis Chronic
- group for people who take Pantoprazole and have Pancreatic Disorder
- group for people who take Simvastatin and have Pancreatic Disorder
NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.